Tulipano Stephen J
SEC CIK 1360548 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| STOK | Stoke Therapeutics, Inc. | CFO | 20.7K | — | $25.1K | 3 | 2022-06-02 | 2024-03-19 |
Most active insiders at STOK, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Krainer Adrian R. | Dir | — | $3.90M |
| 2 | Kaye Edward M. MD | Dir | — | $3.18M |
| 3 | Ticho Barry | Chief MEDICAL Off | — | $1.98M |
| 4 | Allan Jonathan | GC, CORP SEC | — | $1.56M |
| 5 | TZIANABOS ARTHUR | Interim Executive COB, Dir | — | $174.2K |
| 6 | Leggett Thomas | CFO | — | $147.1K |
| 7 | Hoitt Jason | Chief Patient Off | — | $119.3K |
| 8 | LEVIN ARTHUR A | Dir | — | $22.3K |
Tulipano Stephen J made no open-market trades at STOK in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-19 | 2024-03-15 | STOK | Stoke Therapeutics, Inc. | Tulipano Stephen J | CFO | M - OptEx | $0.00 | +13.1K | 24.9K | +111% | $0 |
| D | 2024-03-19 | 2024-03-19 | STOK | Stoke Therapeutics, Inc. | Tulipano Stephen J | CFO | S - Sale+OE | $6.10 | -4,116 | 20.7K | -17% | -$25.1K |
| D | 2022-06-03 | 2022-06-02 | STOK | Stoke Therapeutics, Inc. | Tulipano Stephen J | CFO | M - OptEx | $4.48 | +11.2K | 11.8K | +1,854% | +$50.0K |
Purchase Sale Sale after option exercise All abbreviations